| Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis J Bolaños-Meade, M Hamadani, J Wu, MM Al Malki, MJ Martens, ... New England Journal of Medicine 388 (25), 2338-2348, 2023 | 119 | 2023 |
| Early complications after biliary enteric anastomosis for benign diseases: a retrospective analysis SN Zafar, MR Khan, R Raza, MN Khan, M Kasi, A Rafiq, OH Jamy BMC surgery 11, 1-5, 2011 | 65 | 2011 |
| Post-transplant cyclophosphamide, tacrolimus, and mycophenolate mofetil as the new standard for graft-versus-host disease (GVHD) prophylaxis in reduced intensity conditioning … SG Holtan, M Hamadani, J Wu, MM Al Malki, L Runaas, H Elmariah, ... Blood 140 (Supplement 2), LBA-4-LBA-4, 2022 | 49 | 2022 |
| Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph … MJ Wieduwilt, W Stock, A Advani, S Luger, RA Larson, M Tallman, ... Leukemia 35 (7), 2076-2085, 2021 | 43 | 2021 |
| Clinical applications of the pedicled anterolateral thigh flap in penile reconstruction M Rashid, A Aslam, S Malik, MS Tamimy, S Aman, O Jamy Journal of plastic, reconstructive & aesthetic surgery 64 (8), 1075-1081, 2011 | 36 | 2011 |
| Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis S Giri, M Chi, B Johnson, D McCormick, O Jamy, VR Bhatt, MG Martin Leukemia Research 39 (12), 1342-1346, 2015 | 33 | 2015 |
| Influence of insurance and marital status on outcomes of adolescents and young adults with acute lymphoblastic leukemia AE Fintel, O Jamy, MG Martin Clinical Lymphoma Myeloma and Leukemia 15 (6), 364-367, 2015 | 23 | 2015 |
| Olverembatinib (HQP1351) overcomes ponatinib resistance in patients with heavily pretreated/refractory chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute … E Jabbour, PB Koller, VG Oehler, OH Jamy, S Mukherjee, AM Hunter, ... Blood 140 (Supplement 1), 200-202, 2022 | 21 | 2022 |
| Adaptation of remote symptom monitoring using electronic patient-reported outcomes for implementation in real-world settings GB Rocque, DAN Dent, SA Ingram, NE Caston, HB Thigpen, FR Lalor, ... JCO Oncology Practice 18 (12), e1943-e1952, 2022 | 20 | 2022 |
| Genomic alterations in neuroendocrine cancers of the ovary G Yaghmour, P Prouet, E Wiedower, OH Jamy, R Feldman, JC Chandler, ... Journal of Ovarian Research 9, 1-5, 2016 | 18 | 2016 |
| Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis GSG Murthy, S Kim, N Estrada-Merly, MB Abid, M Aljurf, A Assal, T Badar, ... Haematologica 108 (7), 1900, 2023 | 17 | 2023 |
| Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients M Boyiadzis, MJ Zhang, K Chen, H Abdel-Azim, MB Abid, M Aljurf, ... Leukemia 37 (5), 1006-1017, 2023 | 16* | 2023 |
| Induction of acute myeloid leukemia with idarubicin, cytarabine and cladribine E Wiedower, O Jamy, MG Martin Anticancer research 35 (11), 6287-6290, 2015 | 15 | 2015 |
| Population-based analysis of the clinical features of primary small cell carcinoma of the ovary O Jamy, G Yaghmour, F Hare, MG Martin Anticancer research 35 (5), 3091-3095, 2015 | 15 | 2015 |
| Venetoclax with chemotherapy in relapse/refractory early T-cell precursor acute lymphoblastic leukemia S Arora, P Vachhani, K Bachiashvili, O Jamy Leukemia & Lymphoma 62 (9), 2292-2294, 2021 | 14 | 2021 |
| Male breast cancer: a 24 year experience of a tertiary care hospital in Pakistan O Jamy, A Rafiq, A Laghari, T Chawla Asian Pacific Journal of Cancer Prevention 16 (4), 1559-1563, 2015 | 14 | 2015 |
| How center volumes affect early outcomes in acute myeloid leukemia AW Hahn, O Jamy, S Nunnery, G Yaghmour, S Giri, R Pathak, MG Martin Clinical Lymphoma Myeloma and Leukemia 15 (11), 646-654, 2015 | 13 | 2015 |
| Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemia S Arora, C Zainaldin, S Bathini, U Gupta, S Worth, K Bachiashvili, ... Leukemia Research 117, 106844, 2022 | 8 | 2022 |
| Risk of cytomegalovirus infection with post-transplantation cyclophosphamide in haploidentical and HLA-matched unrelated donor transplantation O Jamy, C Hebert, S Dunn-Valadez, T Magnusson, N Watts, G McGwin, ... Transplantation and cellular therapy 28 (4), 213. e1-213. e6, 2022 | 8 | 2022 |
| Impact of sociodemographic factors on early mortality in acute promyelocytic leukemia in the United States: A time‐trend analysis OH Jamy, A Dhir, LJ Costa, AC Xavier Cancer 128 (2), 292-298, 2022 | 8 | 2022 |
